These factors included age, gender, BMI, diabetes, HIV status, previous treatment, ALT, platelet counts, HCV sub-genotype, HCV RNA level, fibrosis staging, steatosis grading and the SNP genotypes, as well as BMI change at FUw72. This evidence concerns the gene GPT and diabetes mellitus.